State Street’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.6M | Buy |
244,727
+49,071
| +25% | +$2.79M | ﹤0.01% | 2303 |
|
|
2025
Q4 | $8.27M | Buy |
195,656
+66,657
| +52% | +$3.73M | ﹤0.01% | 2739 |
|
|
2025
Q3 | $7.34M | Buy |
128,999
+78,894
| +157% | +$2.61M | ﹤0.01% | 2809 |
|
|
2025
Q2 | $1.29M | Sell |
50,105
-167,114
| -77% | -$1.88M | ﹤0.01% | 3437 |
|
|
2025
Q1 | $2.22M | Sell |
217,219
-921
| -0.4% | -$12K | ﹤0.01% | 3205 |
|
|
2024
Q4 | $3.04M | Sell |
218,140
-4,909
| -2% | -$86.6K | ﹤0.01% | 3172 |
|
|
2024
Q3 | $4.35M | Buy |
223,049
+23,717
| +12% | +$452K | ﹤0.01% | 3028 |
|
|
2024
Q2 | $3.71M | Buy |
199,332
+153,210
| +332% | +$3.23M | ﹤0.01% | 3057 |
|
|
2024
Q1 | $646K | Sell |
46,122
-1,620
| -3% | -$17K | ﹤0.01% | 3581 |
|
|
2023
Q4 | $405K | Hold |
47,742
| – | – | ﹤0.01% | 3692 |
|
|
2023
Q3 | $427K | Sell |
47,742
-654
| -1% | -$6.3K | ﹤0.01% | 3710 |
|
|
2023
Q2 | $418K | Sell |
48,396
-417,010
| -90% | -$4.45M | ﹤0.01% | 3737 |
|
|
2023
Q1 | $4.91M | Sell |
465,406
-23,633
| -5% | -$715K | ﹤0.01% | 2998 |
|
|
2022
Q4 | $16.6M | Sell |
489,039
-34,754
| -7% | -$1.68M | ﹤0.01% | 2375 |
|
|
2022
Q3 | $25.1M | Sell |
523,793
-58,138
| -10% | -$3.46M | ﹤0.01% | 2053 |
|
|
2022
Q2 | $33.2M | Buy |
581,931
+195,244
| +50% | +$12.3M | ﹤0.01% | 1900 |
|
|
2022
Q1 | $31.3M | Buy |
386,687
+33,917
| +10% | +$5.02M | ﹤0.01% | 2072 |
|
|
2021
Q4 | $71.5M | Buy |
352,770
+42,829
| +14% | +$9.29M | ﹤0.01% | 1555 |
|
|
2021
Q3 | $83.5M | Sell |
309,941
-6,564
| -2% | -$1.58M | ﹤0.01% | 1420 |
|
|
2021
Q2 | $81.5M | Buy |
316,505
+24,599
| +8% | +$6.81M | ﹤0.01% | 1463 |
|
|
2021
Q1 | $87.6M | Sell |
291,906
-6,466
| -2% | -$2.01M | 0.01% | 1329 |
|
|
2020
Q4 | $76.1M | Buy |
298,372
+15,031
| +5% | +$3.88M | ﹤0.01% | 1366 |
|
|
2020
Q3 | $70.5M | Sell |
283,341
-14,302
| -5% | -$4.5M | ﹤0.01% | 1199 |
|
|
2020
Q2 | $103M | Sell |
297,643
-11,127
| -4% | -$3.47M | 0.01% | 933 |
|
|
2020
Q1 | $82.7M | Buy |
308,770
+5,430
| +2% | +$1.68M | 0.01% | 949 |
|
|
2019
Q4 | $98.2M | Sell |
303,340
-191,293
| -39% | -$55.5M | 0.01% | 1068 |
|
|
2019
Q3 | $135M | Buy |
494,633
+18,466
| +4% | +$6.77M | 0.01% | 834 |
|
|
2019
Q2 | $254M | Buy |
476,167
+2,907
| +0.6% | +$1.46M | 0.02% | 630 |
|
|
2019
Q1 | $239M | Buy |
473,260
+20,565
| +5% | +$12.2M | 0.02% | 627 |
|
|
2018
Q4 | $223M | Buy |
452,695
+11,860
| +3% | +$7.16M | 0.02% | 599 |
|
|
2018
Q3 | $403M | Buy |
440,835
+40,574
| +10% | +$34.6M | 0.03% | 484 |
|
|
2018
Q2 | $293M | Sell |
400,261
-21,513
| -5% | -$24.8M | 0.02% | 557 |
|
|
2018
Q1 | $672M | Buy |
421,774
+156,520
| +59% | +$202M | 0.06% | 325 |
|
|
2017
Q4 | $238M | Buy |
265,254
+692
| +0.3% | +$409K | 0.02% | 625 |
|
|
2017
Q3 | $95.2M | Sell |
264,562
-29,323
| -10% | -$9.17M | 0.01% | 1006 |
|
|
2017
Q2 | $86.2M | Buy |
293,885
+29,802
| +11% | +$8.61M | 0.01% | 1034 |
|
|
2017
Q1 | $93M | Sell |
264,083
-6,748
| -2% | -$1.52M | 0.01% | 985 |
|
|
2016
Q4 | $49.8M | Buy |
270,831
+48,722
| +22% | +$9.91M | ﹤0.01% | 1268 |
|
|
2016
Q3 | $57.2M | Buy |
222,109
+4,077
| +2% | +$1.05M | 0.01% | 1152 |
|
|
2016
Q2 | $46.5M | Sell |
218,032
-13,976
| -6% | -$3.12M | 0.01% | 1220 |
|
|
2016
Q1 | $47.9M | Buy |
232,008
+10,091
| +5% | +$1.94M | 0.01% | 1192 |
|
|
2015
Q4 | $56.1M | Sell |
221,917
-92,683
| -29% | -$19.1M | 0.01% | 1118 |
|
|
2015
Q3 | $51.7M | Sell |
314,600
-45,945
| -13% | -$8.13M | 0.01% | 1146 |
|
|
2015
Q2 | $67.7M | Buy |
360,545
+39,927
| +12% | +$6.87M | 0.01% | 1082 |
|
|
2015
Q1 | $52.9M | Buy |
320,618
+46,034
| +17% | +$9.46M | 0.01% | 1202 |
|
|
2014
Q4 | $63.8M | Sell |
274,584
-2,963
| -1% | -$633K | 0.01% | 1091 |
|
|
2014
Q3 | $50.2M | Sell |
277,547
-34,547
| -11% | -$6.61M | 0.01% | 1181 |
|
|
2014
Q2 | $60M | Buy |
312,094
+32,532
| +12% | +$5.75M | 0.01% | 1137 |
|
|
2014
Q1 | $50.8M | Sell |
279,562
-7,480
| -3% | -$1.48M | 0.01% | 1186 |
|
|
2013
Q4 | $48.9M | Buy |
287,042
+62,923
| +28% | +$10.1M | 0.01% | 1205 |
|
|
2013
Q3 | $35.1M | Buy |
224,119
+19,836
| +10% | +$3.67M | ﹤0.01% | 1350 |
|
|
2013
Q2 | $35.4M | Buy |
+204,283
| New | +$31.3M | ﹤0.01% | 1301 |
|
Other funds holding NKTR
BI
TSC
VCM
PM
AC
State Street's NKTR Position: Q1 2026 in Review
State Street increased its Nektar Therapeutics (NKTR) stake by 25% in Q1 2026, buying an estimated $2.79M and bringing the position to 244,727 shares worth $17.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2303.
State Street first reported a position in NKTR in Q2 2013 and has held it in 52 quarters since. The position peaked at $672M in Q1 2018. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.
- State Street held 244,727 shares of Nektar Therapeutics worth $17.6M as of Q1 2026.
- State Street bought 49,071 Nektar Therapeutics shares in Q1 2026, an estimated $2.79M.
- Nektar Therapeutics made up ﹤0.01% of State Street's portfolio in Q1 2026, its #2303 holding.
- State Street first reported a position in Nektar Therapeutics in Q2 2013 and has held it in 52 quarters since.
- State Street's Nektar Therapeutics position peaked at $672M in Q1 2018.
- 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.